Roivant Sciences (ROIV) Insider Trading & Ownership $11.93 -0.01 (-0.08%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$11.94 +0.01 (+0.04%) As of 08/29/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Roivant Sciences (NASDAQ:ROIV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$336.90MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$120.51M Get ROIV Insider Trade Alerts Want to know when executives and insiders are buying or selling Roivant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ROIV Insider Buying and Selling by Quarter Roivant Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/20/2025Eric VenkerCEOSell100,000$11.72$1,172,000.00 7/21/2025Eric VenkerCEOSell100,000$11.52$1,152,000.00 6/20/2025Eric VenkerCOOSell100,000$11.45$1,145,000.00 6/20/2025Vivek RamaswamyMajor ShareholderSell577,007$11.46$6,612,500.22 6/18/2025Vivek RamaswamyMajor ShareholderSell565,266$11.45$6,472,295.70 6/17/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$11.11$1,001 - $15,0006/6/2025Vivek RamaswamyMajor ShareholderSell200,800$11.19$2,246,952.00 6/4/2025Vivek RamaswamyMajor ShareholderSell547,430$11.34$6,207,856.20 6/3/2025Eric VenkerCOOSell566,278$11.22$6,353,639.16 6/2/2025Eric VenkerCOOSell433,722$11.07$4,801,302.54 5/20/2025Eric VenkerCOOSell100,000$10.95$1,095,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/6/2025Vivek RamaswamyMajor ShareholderSell273,959$11.47$3,142,309.73 4/21/2025Eric VenkerCOOSell100,000$10.22$1,022,000.00 3/24/2025Eric VenkerCOOSell434,478$10.82$4,701,051.96 3/20/2025Eric VenkerCOOSell315,522$11.06$3,489,673.32 2/20/2025Eric VenkerCOOSell100,000$10.65$1,065,000.00 2/13/2025Eric VenkerCOOSell218,041$10.42$2,271,987.22 2/13/2025Rakhi KumarCAOSell227,500$10.43$2,372,825.00 1/21/2025Eric VenkerCOOSell100,000$11.28$1,128,000.00 1/13/2025Sciences Ltd. RoivantDirectorBuy16,845,010$20.00$336,900,200.00 12/30/2024Eric VenkerCOOSell177,704$11.54$2,050,704.16 12/27/2024Eric VenkerCOOSell176,900$11.82$2,090,958.00 12/26/2024Mayukh SukhatmeCIOSell689,495$12.01$8,280,834.95 12/24/2024Mayukh SukhatmeCIOSell185,946$12.00$2,231,352.00 12/20/2024Eric VenkerCOOSell100,000$11.49$1,149,000.00 12/18/2024Mayukh SukhatmeCIOSell412,584$12.05$4,971,637.20 11/20/2024Eric VenkerCOOSell100,000$11.32$1,132,000.00 10/21/2024Eric VenkerCOOSell100,000$11.65$1,165,000.00 9/26/2024Financial Lp QvtDirectorSell876,000$11.82$10,354,320.00 9/24/2024Keith S ManchesterDirectorSell368,052$11.62$4,276,764.24 9/23/2024Matthew GlineCEOSell1,983,257$11.79$23,382,600.03 9/23/2024Rakhi KumarCAOSell250,000$11.89$2,972,500.00 (Data available from 1/1/2013 forward) ROIV Insider Trading Activity - Frequently Asked Questions Who is on Roivant Sciences' Insider Roster? The list of insiders at Roivant Sciences includes Eric Venker, Financial Lp Qvt, Global Investors Lp Viking, Keith S Manchester, Matthew Gline, Mayukh Sukhatme, Pharma Technologies Ltd Dexcel, Rakhi Kumar, Richard Pulik, Sciences Ltd. Roivant, Svf Investments (Uk) Ltd, and Vivek Ramaswamy. Learn more on insiders at ROIV. What percentage of Roivant Sciences stock is owned by insiders? 10.80% of Roivant Sciences stock is owned by insiders. Learn more on ROIV's insider holdings. Which Roivant Sciences insiders have been buying company stock? The following insider purchased ROIV shares in the last 24 months: Sciences Ltd. Roivant ($394,900,208.00). How much insider buying is happening at Roivant Sciences? Insiders have purchased a total of 18,371,326 ROIV shares in the last 24 months for a total of $394,900,208.00 bought. Which Roivant Sciences insiders have been selling company stock? The following insiders have sold ROIV shares in the last 24 months: Eric Venker ($52,403,519.43), Financial Lp Qvt ($10,354,320.00), Keith S Manchester ($83,927,227.44), Matthew Gline ($23,382,600.03), Mayukh Sukhatme ($15,483,824.15), Rakhi Kumar ($6,576,096.00), Svf Investments (Uk) Ltd ($126,000,000.00), and Vivek Ramaswamy ($57,831,913.85). How much insider selling is happening at Roivant Sciences? Insiders have sold a total of 31,795,007 Roivant Sciences shares in the last 24 months for a total of $375,959,500.90 sold. Which members of congress are trading Roivant Sciences? Lisa C. McClain (R-MI) has bought shares of Roivant Sciences in the last year totaling $8,000. Roivant Sciences Key ExecutivesMr. Matthew Gline (Age 40)CEO & Director Compensation: $1.77MDr. Eric Venker M.D. (Age 37)Pharm.D., President & COO Compensation: $1.28MDr. Mayukh Sukhatme M.D. (Age 48)President, Chief Investment Officer & Director Compensation: $1.72MMr. Richard Pulik (Age 45)Chief Financial Officer Ms. Rakhi Kumar (Age 44)Chief Accounting Officer Dr. Huafeng Xu Ph.D.Chief Technology OfficerMr. Jo ChenGeneral CounselMs. Kelly GraffHead of PeopleMs. Marianne L. Romeo (Age 56)Head of Global Transactions & Risk Management Mr. Alex GasnerExecutive Vice President of Roivant Health More Insider Trading Tools from MarketBeat Related Companies INSM Insider Trading BNTX Insider Trading TEVA Insider Trading SMMT Insider Trading GMAB Insider Trading VTRS Insider Trading MRNA Insider Trading BBIO Insider Trading ELAN Insider Trading VRNA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:ROIV) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
